Rosenheimer Str. 6-8, 83043 Bad Aibling, Germany · info@clinicum-stgeorg.de
Integrative Cancer Care
Prostate cancer is one of the most common cancers in men. Our integrative approach combines prostate-specific hyperthermia, targeted biological therapies, and immune support to treat the disease while preserving quality of life.
A Gleason score, a PSA graph, and two options that both frightened you: surgery with its risks, or waiting. You want to know whether there is a middle path, and whether real monitoring stands behind it.
This page explains how we treat prostate cancer with prostate-specific hyperthermia and supporting therapies, and who is a candidate.
Prostate cancer ranges from slow-growing, low-risk tumors that may never cause symptoms, to aggressive cancers that can spread throughout the body. Treatment decisions depend heavily on the stage, Gleason score, PSA dynamics, and the patient’s overall health and preferences.
Many men face a difficult choice between radical treatments (surgery, radiation) with significant side effects — including incontinence and erectile dysfunction — and active surveillance with the anxiety of living with an untreated cancer.
At St. George Hospital, we offer a third path: integrative oncology protocols that can be used as primary treatment for localized disease, as complementary therapy alongside conventional treatment, or as a strategy for recurrent or advanced prostate cancer. Our prostate cancer program is led by Dr. Martin Rößner, Chief Physician for Internal Medicine and Oncology, who brings extensive experience in individualized, integrative cancer care.
Our specialized transrectal hyperthermia system delivers controlled heat directly to the prostate, damaging cancer cells while sparing surrounding tissue. This targeted approach can be used as a primary treatment for localized disease or as an adjunct to other therapies. Sessions are 60-90 minutes with continuous temperature monitoring.
For patients requiring chemotherapy, our insulin-potentiated approach delivers drugs at significantly reduced doses with fewer side effects. This is particularly relevant for advanced prostate cancer or cases that have progressed through hormone therapy.
Dendritic cell therapy, thymus peptides, and natural killer cell stimulation activate the immune system's ability to recognize and attack prostate cancer cells. Immune therapy is particularly valuable for preventing recurrence and managing micrometastatic disease.
Rather than simply suppressing all testosterone (which causes significant side effects), our approach includes careful hormonal assessment, estrogen metabolism evaluation, and nuanced hormonal strategies that address the cancer while minimizing quality-of-life impact.
Light-sensitive compounds that preferentially accumulate in prostate tissue can be activated to selectively destroy cancer cells. PDT offers a minimally invasive option for localized prostate cancer with minimal impact on surrounding structures.
Anti-inflammatory nutrition, targeted supplementation (vitamin D, selenium, modified citrus pectin), exercise guidance, and stress management form an essential part of our comprehensive prostate cancer protocol.
Targeted transrectal heat therapy specifically designed for prostate tumors, enhancing treatment response while preserving organ function.
What prostate hyperthermia involves →Systemic heat therapy activates immune defenses and enhances drug delivery for advanced or metastatic prostate cancer.
What a whole-body hyperthermia session involves →Low-dose insulin-potentiated chemotherapy offers a gentler treatment option with fewer side effects for prostate cancer patients.
How IPT low-dose chemotherapy works →Mistletoe therapy and immune modulation strengthen the body's natural surveillance against prostate cancer progression.
What immune therapy involves →Focal photodynamic therapy offers a tissue-sparing approach for localized prostate cancer treatment.
What photodynamic therapy involves →“We couldn’t have had a more positive experience and we are very hopeful. We made so many friends and met lovely patients from all over the world who touched our hearts with their faith and love.”
International Patient’s Spouse
Prostate Cancer, 2025
A video consultation in English before you travel. A physician reviews your findings first; we reply by email within one business day (Mon–Fri).
Mon–Thu 08:00–17:00, Fri 08:00–14:00 (CET/CEST)+49 8061 398-0info@clinicum-stgeorg.de
St. George Hospital is a specialist hospital, not an emergency department. In a medical emergency in Germany, dial 112.
